메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

ELFBAR and LOST MARY unveil landmark R&D advances and ne…

Nicotine salts, the key vape e-liquid ingredient, studied to improve formulations Over 136,000 tests run in 2025 on product e-liquid, aerosol, material, and reliability 300 testing procedures deployed as standard Continuous innovation and technology applications powered by over 900 patents granted globally LONDON, Dec. 10, 2025 -- World-leading vaping brands ELFBAR and LOST MARY today shared the latest R&D breakthroughs, featuring pioneering research on e-liquid formulations, an all-inclusive patent portfolio, and expanded testing protocols.
- 김갑성 기자
- 2025-12-10 16:00
Stay True to Our Original Aspiration, Forge Ahead into the Futu…

SUZHOU, China, Dec. 10, 2025 -- On December 8, 2025, Alphamab Oncology (Stock Code: 9966.HK) successfully held its "Stay True to Our Original Aspiration, Forge Ahead into the Future" 2025 R&D Day in Shanghai. The event focused on the latest advancements in the field of antibody-drug conjugates (ADCs), comprehensively showcasing the company's R&D achievements in bispecific ADCs and dual-payload ADCs. It also shared a highly differentiated and globally competitive product pipeline and clinical development strategy, while outlining the multidimensional evolution of its world-le
- 김갑성 기자
- 2025-12-10 14:20
DKSH Healthcare Launches Three-Part Whitepaper Series S…

DKSH Business Unit Healthcare Launches a three-part whitepaper series to help healthcare and life science companies explore industry trends and current market pressures to re-think commercial go-to market approaches in the Asia Pacific region. The whitepaper series demonstrates how strategic Commercial Outsourcing partnerships are evolving to deliver sustainable growth, resource agility, and improved patient access – successfully harnessing the region's growing USD 10 billion healthcare outsourcing opportunity. SINGAPORE, Dec. 10, 2025 -- DKSH Business Unit Healthcare has devel
- 김갑성 기자
- 2025-12-10 14:00
European Protected Waveform Consortium Achieves Major Mil…

Demonstration underscores Europe's commitment to secure, resilient, multi-orbit military satellite communications SINT-NIKLAAS, Belgium, Dec. 10, 2025 -- ST Engineering iDirect's EU Satcom Centre of Excellence, ST Engineering iDirect Europe, based in Sint-Niklaas, Belgium, today announced that the European Protected Waveform (EPW) consortium has successfully completed over-the-air testing, marking a critical milestone in Europe's pursuit of strategic autonomy in secure military communications. Conducted on November 26-27, 2025 at Universität der Bundeswehr München, Ge
- 김갑성 기자
- 2025-12-10 14:00
Empowering Modern Mothers: Ddrops® Supports the Health…

KUALA LUMPUR, Malaysia, Dec. 10, 2025 -- Ddrops® participated in the Dear Mom x Ddrops® event, hosted by Innity Group, at IPC Shopping Centre, Malaysia, to engage with modern mothers and emphasize the importance of maternal support, emotional well-being, and self-care. Reflecting the realities of motherhood today, the event featured interactive zones, including the Self-Love Consultation Booth, Sponsored Brands Experience Zone, Dear Me Reflection Wall, and Creator Photo Zone, offering mothers a space to connect, share experiences, and rediscover themselves beyond caregiving. &n
- 김갑성 기자
- 2025-12-10 10:30
Beijing 101 Launches Tri-Action Scalp Revival Treatment, The…

SINGAPORE, Dec. 10, 2025 -- Beijing 101 Hair Consultants is thrilled to announce the launch of its latest treatment innovation – the Tri-Action Scalp Revival Treatment – a systematic, multi-technology hair and scalp treatment that cleanses, nourishes, and rejuvenates the scalp through a defined sequence of professionally guided steps. This new treatment reinforces Beijing 101's pledge to provide effective, state-of-the-art treatment solutions for hair and scalp issues, with Traditional Chinese Medicine (TCM) principles. Developed with precision and a clear methodology, the Tri-
- 김갑성 기자
- 2025-12-10 10:00
MALAYSIA UNVEILS FIRST FLAGSHIP MEDICAL TOURISM HOSPITAL AWARD…

KUALA LUMPUR, Malaysia, Dec. 10, 2025 -- Malaysia Healthcare Travel Council (MHTC) marked a major milestone in its medical tourism journey today with the announcement of the Winner of the Flagship Medical Tourism Hospital (FMTH) Programme, an initiative initiated and led by the Malaysia Healthcare Travel Council (MHTC) to elevate Malaysia's position as the preferred medical tourism destination in the world. The announcement was made during the FMTH 2025 Award Ceremony, held at M Resort & Hotel Kuala Lumpur. The event was officiated by YB Datuk Seri Dr. Dzulkef
- 김갑성 기자
- 2025-12-10 09:40
D3 Bio Secures $108 Million in Series B Financing to Advance G…

SHANGHAI, Dec. 10, 2025 -- D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a $108 million Series B financing round. The funding round was backed by a distinguished group of investors, including IDG Capital and SongQing Capital. Existing investors — WuXi AppTec's Corporate Venture Fund, Temasek, HSG, MPCi, and Medicxi — also contributed to the round. The robust involvement from both new and current investors highlights widespread confidence in D3 Bio's in
- 김갑성 기자
- 2025-12-10 09:30
Innovent Announces First Participant Dosed in a Phase 1 Cli…

[ 메디채널 김갑성 기자 ] SAN FRANCISCO and SUZHOU, China, Dec. 10, 2025 -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major disease areas, announced that the first participant has been successfully dosed in a Phase 1 clinical trial of IBI3011, an anti-human Interleukin 1 receptor accessory protein (IL-1RAP) monoclonal antibody developed by Innovent. This study is a single ascending
- 김갑성 기자
- 2025-12-10 08:26
Lee's Pharmaceutical Holdings Limited Acquires Staccato®…

Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential Synergistic and complementary to Lee's Pharm's existing products pipeline, and Acquisition of rights as licensor and manufacturer of Staccato® alprazolam under a global partnership with UCB HONG KONG, Dec. 10, 2025 -- Nova Pneuma Inc. ("NPI"), the Delaware incorporated and wholly owned subsidiary of Lee's Pharmaceutical Holdings Limited (0950.HK) ("Lee's Pharm" or the "Company"), announced today the assets acquisi
- 김갑성 기자
- 2025-12-10 08:00

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2025-12-10_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 12월 10일 18시 20분